Hepatobiliary & Pancreatic Diseases International, an esteemed journal published by Elsevier, stands as a vital resource within the field of gastroenterology and hepatology. Established in 2002, this journal has developed a significant reputation, currently ranked in the second quartile (Q2) in both categories as of 2023, showcasing its commitment to high-quality research and clinical studies. Based in Singapore, Hepatobiliary & Pancreatic Diseases International serves as an essential platform for researchers, clinicians, and healthcare professionals to share innovative findings, therapeutic approaches, and advancements in the understanding of hepatobiliary and pancreatic diseases. Although the journal does not currently offer Open Access, its rigorous peer-review process ensures that published articles maintain the highest scientific standards, fostering knowledge dissemination among the global research community. With a convergence period extending to 2024, this journal continues to play a pivotal role in enhancing the understanding and treatment of complex gastrointestinal conditions, making it a must-read for anyone engaged in this dynamic field.

Journal of the Pancreas is a pivotal academic publication dedicated to advancing our understanding of pancreatic diseases and disorders. Published by E S Burioni Ricerche Bibliografiche, this journal aims to disseminate novel research findings, case studies, and reviews pertaining to the diagnosis, treatment, and management of pancreatic conditions. With its ISSN 1590-8577, the journal has made significant contributions to the medical field since its inception in 2000, although it ceased its coverage in Scopus in 2015. The Journal of the Pancreas is particularly valuable for researchers, healthcare professionals, and students in gastroenterology and related fields, as it supports evidence-based practices and promotes collaboration in the exploration of pancreatic health. The importance of this journal is underscored by its commitment to providing high-quality, peer-reviewed research that informs clinical approaches and enhances patient outcomes.

Thoracic Cancer is a distinguished open-access journal published by WILEY, dedicated to advancing the field of thoracic oncology. Since its establishment in 2010, the journal has emerged as a crucial platform for the dissemination of innovative research and clinical studies relating to lung cancer and other thoracic malignancies. With a commendable impact reflected in its 2023 Q2 rankings in the categories of Medicine (Miscellaneous), Oncology, and Pulmonary and Respiratory Medicine, the journal features high-quality articles that are vital for researchers, clinicians, and students aspiring to enhance their understanding of thoracic cancers. Operating out of Australia, Thoracic Cancer has embraced a commitment to open access since 2015, ensuring that vital research is readily available to a global audience. The journal's rigorous peer-review process and emphasis on novel findings make it an indispensable resource for professionals seeking to stay at the forefront of this rapidly evolving field.

International Journal of Hepatobiliary and Pancreatic Diseases (ISSN: 2230-9012) is a pivotal publication dedicated to advancing knowledge in the fields of hepatology, biliary tract, and pancreatic diseases. Published by EDORIUM JOURNALS, this esteemed journal aims to provide a platform for cutting-edge research, critical reviews, and clinical studies that address complex issues affecting the liver, biliary system, and pancreas. With a strong commitment to open access, the journal facilitates the dissemination of vital findings to researchers, clinicians, and healthcare professionals worldwide. Recognizing the importance of these disciplines in combating global health challenges, the International Journal of Hepatobiliary and Pancreatic Diseases welcomes submissions that contribute to the understanding of pathophysiology, treatment advancements, and innovative surgical techniques. For researchers eager to impact patient care and medical knowledge, this journal serves as an essential resource in the ongoing dialogue on liver and pancreatic health.

GASTROINTESTINAL ENDOSCOPY, published by MOSBY-ELSEVIER, stands as a leading journal in the fields of gastroenterology and radiology, boasting an impressive impact factor that reflects its esteemed position within the academic community. Established in 1965 and set to continue through 2024, this journal is critical for disseminating high-quality research that informs clinical practice and enhances patient care. With a robust Scopus ranking — 25th out of 333 in Radiology, Nuclear Medicine and Imaging, and 15th out of 167 in Gastroenterology — it proudly maintains a #1 quartile status in both disciplines as of 2023. While the journal does not offer open access, it remains invaluable for researchers, professionals, and students seeking to stay ahead in the rapidly evolving fields of gastrointestinal pathology and innovative endoscopic procedures. Its comprehensive scope encompasses technological advancements, clinical studies, and critical reviews, making it a vital resource for advancing knowledge and supporting professional development.

Bratislava Medical Journal-Bratislavske Lekarske Listy, published by AEPRESS SRO, is a prominent scholarly journal dedicated to the field of medicine, particularly emphasizing multifaceted aspects of healthcare and medical research. With an ISSN of 0006-9248 and an E-ISSN of 1336-0345, this journal has been a valued resource since its inception in 1950, continuously evolving to meet the needs of the global medical community. It holds a respectable Q3 ranking in the Medicine category for 2023 and ranks 204 out of 636 journals in General Medicine according to Scopus, placing it in the 68th percentile. While the journal currently does not offer Open Access options, it showcases a repository of valuable research articles and clinical studies aimed at fostering knowledge advancement in Slovakia and beyond. Researchers, medical professionals, and students will find the Bratislava Medical Journal an indispensable source of insights and information crucial for staying abreast of the latest trends and findings in the medical field.

Journal of Pancreatology, published by Lippincott Williams & Wilkins, serves as a vital resource in the fields of Endocrinology, Diabetes and Metabolism, and Hepatology. This Open Access journal, established to disseminate cutting-edge research and advancements in pancreatic health, has witnessed a substantial rise since its inception in 2018, with converged publications spanning through 2024. Although currently ranked in the Q3 category across multiple disciplines, the journal continually seeks to elevate the discourse around pancreatic diseases and endocrine functions through high-quality articles and comprehensive studies. Researchers, professionals, and students alike will find valuable insights that can drive future investigations and clinical applications. The journal is accessible from anywhere in the world, ensuring that critical knowledge in this important field reaches a wide audience without barriers. Explore the Journal of Pancreatology to stay at the forefront of pancreatic research and contribute to meaningful developments in medical science.

HPB is a premier journal dedicated to advancing the fields of Gastroenterology and Hepatology, published by Elsevier Science Ltd. With an impressive impact factor reflective of its high-quality research output, HPB has earned its place as a Q1 journal in Gastroenterology and Q2 in Hepatology as of 2023. The journal, available in both print and electronic formats (ISSN: 1365-182X; E-ISSN: 1477-2574), serves as a vital platform for multidisciplinary research, encompassing clinical and experimental studies, aimed at improving patient care and outcomes related to liver and biliary diseases. Since its inception in 2000, HPB has published influential articles that have shaped practice and policy in the field. Located in the United Kingdom, at 125 London Wall, London EC2Y 5AS, the journal is poised to continue its mission of fostering innovation and collaboration among researchers, healthcare professionals, and academicians worldwide.

Cancers is a leading peer-reviewed journal published by MDPI, dedicated to advancing the field of oncology and cancer research. Established in 2009 and based in Switzerland, this Open Access journal provides a platform for the rapid dissemination of high-quality research findings, reviews, and clinical studies related to all aspects of cancer biology and treatment. With an impressive impact factor and recognized as Q1 in Oncology and Q2 in Cancer Research for 2023, Cancers strives to foster a collaborative environment among researchers, healthcare professionals, and students seeking to deepen their knowledge and understanding of cancer. The journal’s commitment to accessibility and its broad scope make it an invaluable resource for anyone passionate about combating cancer and improving patient outcomes. For more information and to access its diverse publications, visit the journal’s website.

Vascular Medicine is a premier academic journal for researchers and practitioners in the field of cardiovascular health, published by SAGE Publications Ltd. With an ISSN of 1358-863X and E-ISSN 1477-0377, this esteemed journal has been at the forefront of publishing quality research since its inception in 1992, with convergence extending to 2024. Ranked in the Q2 category for both Cardiology and Cardiovascular Medicine as well as for miscellaneous Medicine in 2023, it is recognized for its significant contributions to advancing knowledge and clinical practice within these domains. Its Scopus ranking situates it at #91 out of 387 in the field, reflecting its high impact and the relevance of its published research, which is crucial for addressing the challenges in vascular health today. Although it is not an open-access journal, Vascular Medicine remains dedicated to disseminating vital findings that bridge the gap between research and clinical application, making it an essential resource for medical researchers, healthcare professionals, and students alike.